Skip to main content
. 2022 Feb 2;11:2021-8-12. doi: 10.7573/dic.2021-8-12

Table 1.

Patient characteristics.

Variable Control group (n=30) TRT >1 year (n=33) Total (n=63) p value
Age (years) 45±12.2 49.1±11.5 47.2±11.9 0.18
Height (m) 1.77±0.06 1.76±0.07 1.76±0.07 0.60
Weight (kg) 101.1±23.2 95.8±17.5 98.3±20.4 0.45
BMI (kg/m2) 31.9±6.3 30.9±5.6 31.4±5.93 0.54
SBP (mmHg) 136.7±22.4 127.1±14.9 131.7±19.3 0.04
DBP (mmHg) 91.2±16.1 83.5±10.0 87.1±13.7 0.02
Smoker 4 (13.3%) 4 (13.3%) 8 (12.7%) 0.88
Hypertense 24 (80%) 7 (21.2%) 31 (49.2%) <0.001
Diabetic 7 (23.3%) 3 (9.1%) 10 (15.9%) 0.53
TRT duration (months) 4.2 (±3.5) 28.8 (±13.3) 17.1 (±15.8) <0.001
Haemoglobin (g/dL) 14.8±1.6 15.6±13 15.2±1.5 0.06
LDL (mg/dL) 111.6±29.6 97.8±40.5 104.4±36.1 0.08
Cholesterol (mg/dL) 181.7±33.5 170.5±46.9 175.9±41.1 0.20
HDL (mg/dL) 38.2±7.1 44.3±14.2 41.4±11.7 0.049
Glycemia (mg/dL) 102±16.7 100±22.2 100.9±19.7 0.23
HbA1c (%) 6.26±2.6 6.0±1.5 6.1±2.1 0.86
CRP (mg/dL) 3.8±5.8 1.7±2.8 2.7±4.6 0.003
Adiponectin (μg/mL) 5.8±2.3 5.5±4.9 5.7±3.9 0.11
TT (ng/dL) 282.5±152.9 493.9±287.1 393.2±254.5 <0.001
LH (mUI/mL) 3.5±2.7 1.5±1.7 2.5±2.4 <0.001
FSH (mUI/mL) 4.8±6.0 3.0±3.8 3.9±5.0 0.01
SHBG (nmol/L) 21.5±7.6 28.9±26.4 25.4±20.0 0.09
Prolactin (ng/mL) 9.7±4.4 8.9±4.0 9.3±4.2 0.43
Cortisol (μg/dL) 11.4±4.3 12.6±4.6 12.1±4.5 0.27
TSH (UI/mL) 2.3±1.2 2.3±1.7 2.3±1.5 0.44
Total PSA (ng/mL) 0.57±0.34 1.07±0.85 0.83±0.70 0.02

Data are presented as mean (±standard deviation) and frequency (valid percentage); p values refer to Mann–Whitney U tests (continuous) and χ2 tests (categorical).

BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; LDL, low-density lipoprotein; HDL, high-density lipoprotein; CRP, C-reactive protein; TT, total testosterone; LH, luteinizing hormone; SHBG, sex hormone-binding globulin; TSH, thyroid-stimulating hormone; PSA, prostate-specific antigen.